GGHC
MYOK

Gilder Gagnon Howe & Co’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-12,395
Closed -$1.69M – 368
2020
Q3 		$1.69M Buy
12,395
+4,833
+64% +$514K 0.01% 245
2020
Q2 		$731K Buy
+7,562
New +$631K 0.01% 247

Gilder Gagnon Howe & Co's MYOK Position: Q4 2020 in Review

Gilder Gagnon Howe & Co sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 12,395 shares — an estimated $1.69M sold.

Gilder Gagnon Howe & Co first reported a position in MYOK in Q2 2020 and held it in 2 quarters. The position peaked at $1.69M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

  • Gilder Gagnon Howe & Co reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 12,395 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $1.69M.
  • Gilder Gagnon Howe & Co first reported a position in MyoKardia, Inc. Common Stock in Q2 2020 and held it in 2 quarters.
  • Gilder Gagnon Howe & Co's MyoKardia, Inc. Common Stock position peaked at $1.69M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Gilder Gagnon Howe & Co's 13F filing for Q4 2020, filed 16 Feb 2021.